ARTICLE | Politics & Policy

FTC files antitrust suit on Androgel deal

September 10, 2014 2:52 AM UTC

The U.S. Federal Trade Commission (FTC) filed a suit alleging several drug makers engaged in anticompetitive behavior by striking a deal to delay the availability of generic versions of AndroGel testosterone gel.

FTC's suit, filed Tuesday in the U.S. District Court for the Eastern District of Pennsylvania, alleges that AbbVie Inc. (NYSE:ABBV) and Besins Healthcare filed "sham" patent infringement lawsuits against generic drug marketers Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Perrigo Co. plc (NYSE:PRGO; Tel Aviv:PRGO). ...